| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/02/2007 | US7157246 RNA polymerase I transcription factor TIF-IA |
| 01/02/2007 | US7157245 Neisserial vaccine compositions and methods |
| 01/02/2007 | US7157244 Adenosine receptor |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157221 Processes for making protein hydrolysates from animal peptone and for preserving mucosa |
| 01/02/2007 | US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1. |
| 01/02/2007 | US7157088 Surface protein of Leptospira |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157085 Method for treating IgE-mediated disorders |
| 01/02/2007 | CA2217236C Monoclonal antibody for immunoassay of detergents and their degradation products and its use |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/28/2006 | WO2006138610A2 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof |
| 12/28/2006 | WO2006138322A2 Total amino acid stabilization during cell-free protein synthesis |
| 12/28/2006 | WO2006138225A2 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 12/28/2006 | WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 12/28/2006 | WO2006137354A1 Antibody having inhibitory effect on amyloid fibril formation |
| 12/28/2006 | WO2006137209A1 Dna, vector, transformant and method for producing apa protein |
| 12/28/2006 | WO2006136164A1 Mutant cells suitable for recombinant polypeptide production |
| 12/28/2006 | WO2006136006A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
| 12/28/2006 | WO2006110748A3 Response gene to complement 32 (rgc-32) in disease |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006050491A3 Methods for antibody engineering |
| 12/28/2006 | WO2006047357A3 Human ly6-big molecules and methods of use |
| 12/28/2006 | WO2006045116A3 In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria |
| 12/28/2006 | WO2005086637A3 Anthrax antigens and methods of use |
| 12/28/2006 | WO2005079525A3 A method for the production of transgenic proteins useful in the treatment of obesity and diabetes |
| 12/28/2006 | WO2003072714A3 Follistatin domain containing proteins |
| 12/28/2006 | US20060294620 use of amylases of the invention in starch conversion processes, including production of high fructose corn syrup (HFCS), ethanol, dextrose, and dextrose syrups; polypeptides having thermostable amylase activity |
| 12/28/2006 | US20060294615 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
| 12/28/2006 | US20060294614 Orphan receptors; drug screening; host cells |
| 12/28/2006 | US20060294612 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 12/28/2006 | US20060294608 Novel haemopoietin receptor and genetic sequences encoding same |
| 12/28/2006 | US20060294607 Human podocalyxin alternative-spliced forms and uses thereof |
| 12/28/2006 | US20060294605 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 12/28/2006 | US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases |
| 12/28/2006 | US20060294601 Compositions, organisms and methodologies employing a novel human kinase |
| 12/28/2006 | US20060293506 Antibodies directed to PDGFD and uses thereof |
| 12/28/2006 | US20060293505 Crystal of a truncated protein construct containing a coagulation factor VIII C2 domain in the presence or absence of a bound ligand and methods of use thereof |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/28/2006 | US20060293235 HGF beta chain variants |
| 12/28/2006 | US20060293234 Interaction between MUC1 and beta -catenin can be interrupted using polypeptides or antibodies that specifically bind to the binding site on MUC1, whereby interruption provides the beneficial effect of inhibiting, reducing, and/or retarding invasiveness and metastasis |
| 12/28/2006 | US20060293230 Expression and secretion of icIL-1 receptor antagonist type II |
| 12/28/2006 | US20060293229 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 12/28/2006 | US20060292678 Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof |
| 12/28/2006 | US20060292674 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 12/28/2006 | US20060292672 Cell lines for expressing enzyme useful in the preparation of amidated products |
| 12/28/2006 | US20060292671 utilizes mannitol, arabitol, glucitol, or glycerol to induce expression of a target polypeptide from an inducible promoter, allowing for the use of an inexpensive and stable carbon source inducer in the fermentation processes for the production of recombinant peptides |
| 12/28/2006 | US20060292670 Nell peptide expression systems and bone formation activity of nell peptide |
| 12/28/2006 | US20060292669 Mammalian prickle gene |
| 12/28/2006 | US20060292668 Nuclear factor of activated t cell receptor |
| 12/28/2006 | US20060292667 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone |
| 12/28/2006 | US20060292665 Glutaryl amidases and their uses |
| 12/28/2006 | US20060292644 Novel tumor-associated marker |
| 12/28/2006 | US20060292643 Recognition molecules for the treatment and detection of tumours |
| 12/28/2006 | US20060292639 Splice variant of the vanilloid receptor VR1A |
| 12/28/2006 | US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase |
| 12/28/2006 | US20060292629 Chimeric polypeptides and their use |
| 12/28/2006 | US20060292627 PB39, a gene dysregulated in prostate cancer, and uses thereof |
| 12/28/2006 | US20060292625 Novel human leucine-rich repeat domain containing protein HLLRCR-1 |
| 12/28/2006 | US20060292620 Genes with ES cell-specific expression |
| 12/28/2006 | US20060292613 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 12/28/2006 | US20060292609 Interferon-beta gene therapy using an improved, regulated expression system |
| 12/28/2006 | US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy |
| 12/28/2006 | US20060292596 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 12/28/2006 | US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 12/28/2006 | US20060292591 Genes from the 20q13 amplicon and their uses |
| 12/28/2006 | US20060292587 Polynucleotides encoding insect voltage-gated chloride channel and uses thereof |
| 12/28/2006 | US20060292578 Nucleotide sequences coding thermus filiformis heat resistant transferase with reduced exonuclease activity; for use in DNA sequencing, nucleic acid amplification, cDNA and nucleic synthesis |
| 12/28/2006 | US20060292577 Neoplasia-specific splice variants and methods |
| 12/28/2006 | US20060292573 Human orthologues of WART |
| 12/28/2006 | US20060292557 contacting a biological sample suspected of containing anti-herpes simplex virus type-2 (HSV-2) antibodies with an antigen comprising a nonapeptide and with a second antigen capable of binding specific anti-HSV-2 antibody, to detect the presence or absence of a specific anti-HSV-2 antibody |
| 12/28/2006 | US20060292551 cationic peptides useful in the treatment of dermatitis and viral infections; for topical administration |
| 12/28/2006 | US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception |
| 12/28/2006 | US20060292546 Herg channel-expressing cell |
| 12/28/2006 | US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 12/28/2006 | US20060292176 In ovo vaccine against infectious bursal disease |
| 12/28/2006 | US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 12/28/2006 | US20060292162 Plasma or serum fraction for the treatment or prevention of bacterial infections |
| 12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 12/28/2006 | US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same |
| 12/28/2006 | US20060292153 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 12/28/2006 | US20060292152 used for the for the medical diagnosis and treatment of Alzheimer's disease |
| 12/28/2006 | US20060292146 Isolated PTPMT1 protein which mediates insulin production and uses thereof |
| 12/28/2006 | US20060292145 Human antihuman interleukin-18 antibody, fragment thereof and method for using same |
| 12/28/2006 | US20060292144 Human disintegrin protein |
| 12/28/2006 | US20060292143 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 12/28/2006 | US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 12/28/2006 | US20060292138 Fusion proteins comprising an allergen sequence linked via an IgG hinge region to another polypeptide sequence capable of specifically binding to a native IgG inhibitory receptor containing an immune receptor tyrosine based inhibitory motif |
| 12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
| 12/28/2006 | US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 12/28/2006 | CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof |
| 12/28/2006 | CA2611969A1 Method for identifying modulators of keah6 useful for treating alzheimer's disease |
| 12/28/2006 | CA2611908A1 Total amino acid stabilization during cell-free protein synthesis |
| 12/28/2006 | CA2610839A1 Self-buffering protein formulations |
| 12/28/2006 | CA2609077A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
| 12/28/2006 | CA2608278A1 Immunogenic compositions for chlamydia trachomatis |
| 12/27/2006 | EP1736551A1 Method of producing liquid cell extract for cell-free protein synthesis |
| 12/27/2006 | EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation |